Table:
Characteristic	Median	Range
Number of patients	122
Sex
Female	122
Male	0
Age at relapse (years)	60.5	24 - 87
Months to relapse	109.5	9 - 365
Injected dose (MBq)	126.13	63.94 - 250.63
Injection location
Intratumoral	113
Peritumoral	3
Periareolar	2
Subcutaneous	4
Relapse tumor size	15 mm	3 - 70 mm
Primary treatment
• Surgery
Breast conserving surgery	117	95.9 %
Mastectomy	5	4.1 %
ALND	68	55.7 %
SNB	57	46.7 %
ALND + SNB	32	26.2 %
• Radiotherapy	104	85.2 %
• Chemotherapy	40	32.8 %

Transcribe the diagram into Markdown format.

| Characteristic |  | Median | Range | 
 | --- | --- | --- | --- | 
 | Number of patients | 122 |  |  | 
 | Sex |  |  |  | 
 | Female | 122 |  |  | 
 | Male | 0 |  |  | 
 | <COLSPAN=2> Age at relapse (years) | 60.5 | 24 - 87 | 
 | Months to relapse |  | 109.5 | 9 - 365 | 
 | Injected dose (MBq) |  | 126.13 | 63.94 - 250.63 | 
 | <COLSPAN=4> Injection location | 
 | Intratumoral | 113 |  |  | 
 | Peritumoral | 3 |  |  | 
 | Periareolar | 2 |  |  | 
 | Subcutaneous | 4 |  |  | 
 | Relapse tumor size |  | 15 mm | 3 - 70 mm | 
 | <COLSPAN=4> Primary treatment | 
 | <COLSPAN=4> • Surgery | 
 | Breast conserving surgery | 117 | 95.9 % |  | 
 | Mastectomy | 5 | 4.1 % |  | 
 | ALND | 68 | 55.7 % |  | 
 | SNB | 57 | 46.7 % |  | 
 | ALND + SNB | 32 | 26.2 % |  | 
 | • Radiotherapy | 104 | 85.2 % |  | 
 | • Chemotherapy | 40 | 32.8 % |  |